Medication Quick Facts
📋Overview
Intuniv is an extended-release formulation of the medication guanfacine. It is classified as a central alpha-2A adrenergic receptor agonist and is a non-stimulant treatment. The medication works by targeting and activating specific receptors in the brain, particularly in the prefrontal cortex, to help balance neurological activity.
By interacting with these receptors, the medication helps to strengthen the brain's ability to process signals related to focus and impulse regulation. This mechanism of action allows it to influence behavioral control and cognitive function through a different pathway than stimulant-based therapies.
🛡️ Educational information only
This content is provided for general health education and awareness and is based on publicly available medical information. It is not intended to replace professional medical advice, diagnosis, or treatment, and should not be used to make healthcare decisions. Always seek the guidance of a qualified healthcare professional regarding any medical condition, medication, supplement, or procedure.
Additional Resources
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
